Technical Analysis for VIVO - Meridian Bioscience Inc.

Grade Last Price % Change Price Change
B 20.0 2.67% 0.52
VIVO closed up 2.67 percent on Friday, September 17, 2021, on 1.52 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Flat
Historical VIVO trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
NR7 Range Contraction 0.00%
Gapped Up Strength 0.00%
Hammer Candlestick Bullish 2.67%
Lizard Bullish Bullish Day Trade Setup 2.67%
Bollinger Band Squeeze Range Contraction 2.67%
BB Squeeze + Lower Band Touch Range Contraction 2.67%
Older End-of-Day Signals for VIVO ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Meridian Bioscience Inc. Description

Meridian Bioscience, Inc., a life science company, develops, manufactures, sells, and distributes clinical diagnostic test kits primarily for gastrointestinal, viral, respiratory, and parasitic infectious diseases. The company's diagnostic products principally include C. difficile for the detection of gastrointestinal diseases, such as antibiotic-associated diarrhea; Rotavirus and Adenovirus products for pediatric diarrhea detection; H. pylori for the detection of stomach ulcers; EHEC test for the detection of Enterohemorrhagic E. coli infection and Campy for the detection of Campylobacter jejuni; and Group A Strep and Group B Strep tests for the detection of streptococcus bacterial infections. Its diagnostic products are also used in the detection of viral diseases, such as mononucleosis, herpes simplex, chicken pox, and shingles; organ transplant infections; parasitic diseases, including giardiasis, cryptosporidiosis, and lyme; and respiratory diseases, such as pneumonia, valley fever, influenza, and respiratory syncytial virus. The company also offers transport media that store and preserve specimen samples from patient collection to laboratory testing; and bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, competent cells, and bioresearch reagents used by researchers and other diagnostic companies. In addition, it engages in the contract development and manufacture of proteins and other biologicals under cGMP conditions for use by biopharmaceutical and biotechnology companies engaged in research for new drugs and vaccines; and sale and distribution of diagnostic test kits manufactured by third-party vendors. The company markets its products through direct sales force and independent distributors primarily to hospitals, reference laboratories, and research customers in the United States, Asia, Canada, South America, Australia, Europe, Africa, and the Middle East. Meridian Bioscience, Inc. was founded in 1976 and is headquartered in Cincinnati, Ohio.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Biotechnology Infectious Diseases Antibodies Gastrointestinal Antibiotic Influenza Diagnostic Products Ulcer Bacterial Infections Respiratory Disease Diarrhea Gastrointestinal Disease Ingles Gastrointestinal Diseases Respiratory Diseases Herpes Shingles Fever Viral Disease Herpes Simplex Pneumonia Viral Diseases Nucleotides Zoonoses Organ Transplant Campylobacter Feces Mononucleosis Waterborne Diseases

Is VIVO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 30.65
52 Week Low 15.45
Average Volume 408,712
200-Day Moving Average 21.50
50-Day Moving Average 19.83
20-Day Moving Average 19.92
10-Day Moving Average 19.92
Average True Range 0.74
ADX 10.82
+DI 20.13
-DI 23.68
Chandelier Exit (Long, 3 ATRs) 18.78
Chandelier Exit (Short, 3 ATRs) 21.01
Upper Bollinger Bands 20.71
Lower Bollinger Band 19.13
Percent B (%b) 0.55
BandWidth 7.95
MACD Line -0.06
MACD Signal Line -0.03
MACD Histogram -0.0308
Fundamentals Value
Market Cap 857.25 Million
Num Shares 42.9 Million
EPS 1.07
Price-to-Earnings (P/E) Ratio 18.69
Price-to-Sales 3.19
Price-to-Book 3.26
PEG Ratio 1.33
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 20.69
Resistance 3 (R3) 20.63 20.33 20.58
Resistance 2 (R2) 20.33 20.16 20.37 20.54
Resistance 1 (R1) 20.17 20.05 20.25 20.23 20.50
Pivot Point 19.87 19.87 19.92 19.91 19.87
Support 1 (S1) 19.71 19.70 19.79 19.77 19.50
Support 2 (S2) 19.41 19.59 19.45 19.46
Support 3 (S3) 19.25 19.41 19.43
Support 4 (S4) 19.31